We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$115B
1-Year Est. Return
41.58%
This Fund
S&P 500
This Quarter
Est. Return
+8.84%
1 Year Est. Return
+41.58%
3 Year Est. Return
+119.77%
5 Year Est. Return
+143.7%
10 Year Est. Return
+448.76%
AUM
$82.9B
AUM Growth
+$1.82B
(+2.3%)
Cap. Flow
-$3.2B
Cap. Flow
% of AUM
-3.86%
Top 10 Holdings %
Top 10 Hldgs %
27.48%
Holding
1,503
New
58
Increased
633
Reduced
567
Closed
76
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$256M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$169M |
| 3 |
Eli Lilly
LLY
|
+$156M |
| 4 |
Franco-Nevada
FNV
|
+$115M |
| 5 |
NVIDIA
NVDA
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Pacific Kansas City
CP
|
+$990M |
| 2 |
Pfizer
PFE
|
+$226M |
| 3 |
Amazon
AMZN
|
+$224M |
| 4 |
Johnson & Johnson
JNJ
|
+$220M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$220M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.76% |
| 2 | Financials | 19.43% |
| 3 | Healthcare | 10.94% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Communication Services | 7.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Relay Therapeutics
RLAY
$4.26B
| $3.57M | ﹤0.01% |
216,817
+93,255
| +75% | +$1.67M |
|
827
Snap-on
SNA
$21.2B
| $3.55M | ﹤0.01% |
14,362
+70
| +0.5% | +$17.1K |
|
828
Saia
SAIA
$9.61B
| $3.54M | ﹤0.01% |
13,010
-2,128
| -14% | -$568K |
|
829
Xencor
XNCR
$1.44B
| $3.53M | ﹤0.01% |
126,646
+10,700
| +9% | +$330K |
|
830
Quaker Houghton
KWR
$2.89B
| $3.5M | ﹤0.01% |
17,680
| – | – |
|
|
SKX
831
DELISTED
Skechers
SKX
| $3.46M | ﹤0.01% |
72,752
-508
| -0.7% | -$23K |
|
832
American Homes 4 Rent
AMH
$12.4B
| $3.43M | ﹤0.01% |
108,918
+11,652
| +12% | +$372K |
|
833
SAP
SAP
$226B
| $3.39M | ﹤0.01% |
26,811
-378
| -1% | -$44.3K |
|
834
East-West Bancorp
EWBC
$18.3B
| $3.38M | ﹤0.01% |
60,917
+7,766
| +15% | +$536K |
|
835
Check Point Software Technologies
CHKP
$12.6B
| $3.38M | ﹤0.01% |
25,967
-1,090
| -4% | -$139K |
|
836
AZZ Inc
AZZ
$4.48B
| $3.37M | ﹤0.01% |
81,760
| – | – |
|
837
HDFC Bank
HDB
$124B
| $3.37M | ﹤0.01% |
101,054
-3,880
| -4% | -$130K |
|
838
Exelixis
EXEL
$14.1B
| $3.36M | ﹤0.01% |
173,096
-9,800
| -5% | -$171K |
|
839
Legend Biotech
LEGN
$3.68B
| $3.36M | ﹤0.01% |
69,612
+23,900
| +52% | +$1.17M |
|
|
NARI
840
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $3.32M | ﹤0.01% |
53,828
+20,089
| +60% | +$1.21M |
|
841
PAR Technology
PAR
$719M
| $3.28M | ﹤0.01% |
96,724
+31,600
| +49% | +$1.05M |
|
|
NFNT
842
DELISTED
Infinite Acquisition Corp.
NFNT
| $3.28M | ﹤0.01% |
315,000
| – | – |
|
|
CGAU
843
Centerra Gold
CGAU
$3.44B
| $3.26M | ﹤0.01% |
505,252
+10,210
| +2% | +$63.7K |
|
|
CNH
844
CNH Industrial
CNH
$13.4B
| $3.25M | ﹤0.01% |
212,642
-5,463
| -3% | -$88.4K |
|
845
IAMGOLD
IAG
$8.55B
| $3.25M | ﹤0.01% |
1,192,406
+26,897
| +2% | +$68.4K |
|
846
Capitol Federal Financial
CFFN
$1.12B
| $3.25M | ﹤0.01% |
482,248
+55,100
| +13% | +$448K |
|
847
Constellium
CSTM
$3.85B
| $3.23M | ﹤0.01% |
211,666
-1,472
| -0.7% | -$21.4K |
|
848
A.O. Smith
AOS
$8.61B
| $3.23M | ﹤0.01% |
46,696
+14,166
| +44% | +$921K |
|
849
Mobileye
MBLY
$2.18B
| $3.23M | ﹤0.01% |
74,562
| – | – |
|
850
Hudbay
HBM
$10.4B
| $3.22M | ﹤0.01% |
615,577
+33,291
| +6% | +$175K |
|
Similar funds
VAM
TD Asset Management's Q1 2023 Portfolio in Review
As of Q1 2023, TD Asset Management held 1,503 positions worth $82.9B, up 2.3% from $81B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
TD Asset Management withdrew a net $3.2B in Q1 2023, closing 76 positions and reducing 567 holdings. Its most notable exit was Canadian Pacific Kansas City, an estimated $990M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, TD Asset Management opened a new position in Novo Nordisk worth $25.2M.
- TD Asset Management's largest Q1 2023 buy was Novo Nordisk: 316,140 shares worth $25.2M.
- TD Asset Management added most to Merck in Q1 2023, an estimated $256M increase.
- TD Asset Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $226M.
- TD Asset Management fully exited Canadian Pacific Kansas City in Q1 2023, selling an estimated $990M.
- TD Asset Management's ten largest holdings make up 27% of its $82.9B portfolio in Q1 2023.
- TD Asset Management opened 58 new positions and closed 76 in Q1 2023.
- TD Asset Management's portfolio value rose 2.3% quarter-over-quarter to $82.9B.
Based on TD Asset Management's 13F filing for Q1 2023, filed 10 May 2023.